• No results found

allogeneic haematopoietic stem cell transplantation

Could enteral nutrition improve the outcome of patients with haematological malignancies undergoing allogeneic haematopoietic stem cell transplantation? A study protocol for a randomized controlled trial (the NEPHA study)

Could enteral nutrition improve the outcome of patients with haematological malignancies undergoing allogeneic haematopoietic stem cell transplantation? A study protocol for a randomized controlled trial (the NEPHA study)

... Myeloablative allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a major procedure usually accompanied by multifactorial malnutrition, prompting the recommendation of ...

9

Reconstitution of the T-cell compartment post-allogeneic haematopoietic stem cell transplantation

Reconstitution of the T-cell compartment post-allogeneic haematopoietic stem cell transplantation

... A great deal o f work has been focused on understanding the regulation o f the peripheral T -cell pool, both under normal circumstances and under conditions o f severe lymphopenia. Several studies using mouse ...

256

High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation

High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation

... Our retrospective study included 5 patients who re- ceived HSCT from HLA-mismatched donors. As a well- established treatment option for many hematological diseases, HSCT has significantly lowered the rates of ...

7

Reactivation of resolved hepatitis B virus infection combined with nephrotic syndrome in a patient after allogeneic haematopoietic stem cell transplantation

Reactivation of resolved hepatitis B virus infection combined with nephrotic syndrome in a patient after allogeneic haematopoietic stem cell transplantation

... undergoing stem cell transplantation, antiviral prophylaxis is recommended, and prophylaxis should continue for at least 18 months after stopping immunosuppression and monitoring should continue for ...

5

Adult Allogeneic Haematopoietic Stem Cell Transplantation: A Single Centre Experience in Malaysia

Adult Allogeneic Haematopoietic Stem Cell Transplantation: A Single Centre Experience in Malaysia

... 40. Baron F, Maris MB, Storer BE, Sandmaier BM, Panse JP, Chauncey TR et al. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more ...

7

Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries

Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries

... of allogeneic HSCT in the five countries, in total (rates of 198–311 per 10 million popu- lation per year), and separately for unrelated donor HSCT (106–218 per 10 million population per year) and family donor ...

14

Immune ablation and stem cell therapy in autoimmune disease Immunological reconstitution after high dose immunosuppression and haematopoietic stem cell transplantation

Immune ablation and stem cell therapy in autoimmune disease Immunological reconstitution after high dose immunosuppression and haematopoietic stem cell transplantation

... From a critic’s viewpoint, eradication of autoreactive memory T and B lymphocytes by autologous SCT may be impossible, and allogeneic SCT may be necessary to achieve this goal. A cure may also remain elusive if ...

6

Quality of Life after Haematopoietic Stem Cell Transplantation in a Multiracial Population

Quality of Life after Haematopoietic Stem Cell Transplantation in a Multiracial Population

... There were 10 (16.1%) and 11 (17.7%) patients who rated excellent for their overall quality of life and overall health status respectively (Table II). The mean global health (QoL) score was 71.2 and other functional ...

5

The A B C of Haematopoietic Stem Cell Transplantation

The A B C of Haematopoietic Stem Cell Transplantation

... Haematopoietic stem cell transplantation (HSCT) has progressed rapidly since its introduction about five decades ...of haematopoietic stem cells (HSC). ...

8

Haematopoietic stem cell transplantation in Switzerland

Haematopoietic stem cell transplantation in Switzerland

... of haematopoietic stem cells (HSCT) is an established therapy today and has seen rapid expansion over the last ...the haematopoietic system and for chemo-sensitive, radio-sensitive or immunosensi- ...

10

Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation

Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation

... patients allogeneic transplant may offer the potential for lon- ger remission and potentially ...and allogeneic stem cell transplant (alloSCT) has limited the use of this ...in ...

10

Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation

Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation

... hematopoietic stem cell transplantation is mainly indicated in bone marrow dysfunction related to blood diseases, but also in some rare diseases (adrenoleucodystrophy, mitochondrial ...

13

Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias

Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias

... T- cell numbers were similar, although a faster rate of T-cell recovery was observed following matched-sibling and family-donor ...B- cell engraftment was achieved in nearly all evaluable surviving ...

27

Outcome of allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies.

Outcome of allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies.

... survival rates in MDS when compared with other myeloid malignancies, with the OS after allogeneic stem cell transplant being 40%. Data from Pakistan shows similar trends in survival among patients ...

9

Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation

Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation

... transplantation (allo-HSCT). Although most viral infections present with asymptomatic or subclinical manifestations, viruses may result in fatal complications in severe immunocompromised recipients. Reactivation ...

14

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go

... marrow transplantation without in vitro T cell depletion within the past 10 years (the GIAC ...blood stem cell harvest (G-PB) as the source of stem cell grafts ...sibling ...

8

OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH ACTIVE DISEASE IN ACUTE MYELOID LEUKEMIA

OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH ACTIVE DISEASE IN ACUTE MYELOID LEUKEMIA

... In conclusion; OS and PFS are short in patients who undergo Allo-SCT with active disease so new treat- ment approaches and targeted therapies should be deve- loped in order to overcome active diseases which are re- ...

5

Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation

Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation

... as a marker of “end organ” cardiovascular damage [17,18]. For cardiotoxicity of anticancer drugs are typi- cal low levels of cTnT. The majorities of these tropo- nins are bound to actin and are released slowly. This ...

6

Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversy

Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversy

... The donor sources tested with regard to peripheral blood stem cells, bone marrow, or umbilical cord blood yielded similar outcomes. The data from Lim et al suggest that in the absence of a suitable HLA-matched ...

8

Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapse after Initial Allogeneic Transplant in Childhood Leukemia - A Single Center Experience

Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapse after Initial Allogeneic Transplant in Childhood Leukemia - A Single Center Experience

... Hsct, stem cell source for the second Hsct, disease status at the second Hsct, conditioning regimen for the second Hsct or GVHd after the second Hsct, complete remission or chronic phase at the second Hsct ...

5

Show all 10000 documents...

Related subjects